3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
11
Recruiting
5
Active not recruiting
4
Withdrawn
1
Unknown
1
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
2
Thoracic
2
Head & Neck
2
Gynecologic
2
Genitourinary
2
Gastrointestinal
2
Endocrine
2
Breast
2
Sarcoma
1
Other solid neoplasm
1
NET
1
Dermatologic
1
CNS
1
Conditions
Melanoma
109
Lymphoma, T-Cell, Cutaneous
27
Mycosis Fungoides
22
Skin Neoplasms
20
Sezary Syndrome
19
Lymphoma, Non-Hodgkin
16
Lymphoma, Follicular
14
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Neoplasm Metastasis
13
Lymphoma, Mantle-Cell
13
Lymphoma, Large-Cell, Immunoblastic
13
Lymphoma, Large-Cell, Anaplastic
13
Lymphoma, Large B-Cell, Diffuse
13
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma
13
Leukemia, Lymphocytic, Chronic, B-Cell
13
Burkitt Lymphoma
13
Hodgkin Disease
12
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
11
Immunoblastic Lymphadenopathy
11
Waldenstrom Macroglobulinemia
10
Keratosis, Actinic
10
Breast Neoplasms
10
Uveal Melanoma
9
Lymphoma, Extranodal NK-T-Cell
9
Leukemia, Myeloid, Acute
9
Leukemia, Hairy Cell
9
Intraocular Lymphoma
9
Carcinoma, Basal Cell
9
Neoplasms
8
Interventions
177Lu-octreotide, DOTA(0)-Tyr(3)-
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Neoplasms, Unknown Primary
×
Dermatologic
×
Clear all
NCT04276597
2023-03-10
PUTNET
Excel Diagnostics and Nuclear Oncology Center
Phase 2
Withdrawn